Urinary Hyaluronidase Activity is Closely Related to Vasopressinergic System Following an Oral Water Load in Men: a Potential Role in Blood Pressure Regulation and Early Stages of Hypertension Development

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jul 10

PMID 38982989

Authors

Anna Calvi

Alice Bongrani

Ignazio Verzicco

Giuliano Figus

Vanni Vicini

Pietro Coghi

Alberto Montanari

Aderville Cabassi

Affiliations

Soon will be listed here.

Abstract

Introduction: Blood pressure (BP) regulation is a complex process involving several factors, among which water-sodium balance holds a prominent place. Arginin-vasopressin (AVP), a key player in water metabolism, has been evoked in hypertension development since the 1980s, but, to date, the matter is still controversial. Hyaluronic acid metabolism has been reported to be involved in renal water management, and AVP appears to increase hyaluronidase activity resulting in decreased high-molecular-weight hyaluronan content in the renal interstitium, facilitating water reabsorption in collecting ducts. Hence, our aim was to evaluate urinary hyaluronidase activity in response to an oral water load in hypertensive patients (HT, n=21) compared to normotensive subjects with (NT+, n=36) and without (NT-, n=29) a family history of hypertension, and to study its association with BP and AVP system activation, expressed by serum copeptin levels and urine Aquaporin 2 (AQP2)/creatinine ratio.

Methods: Eighty-six Caucasian men were studied. Water load test consisted in oral administration of 15-20 ml of water/kg body weight over 40-45 min. BP, heart rate, serum copeptin, urine hyaluronidase activity and AQP2 were monitored for 4 hours.

Results: In response to water drinking, BP raised in all groups with a peak at 20-40 min. Baseline levels of serum copeptin, urinary hyaluronidase activity and AQP2/creatinine ratio were similar among groups and all decreased after water load, reaching their nadir at 120 min and then gradually recovering to baseline values. Significantly, a blunted reduction in serum copeptin, urinary hyaluronidase activity and AQP2/creatinine ratio was observed in NT+ compared to NT- subjects. A strong positive correlation was also found between urinary hyaluronidase activity and AQP2/creatinine ratio, and, although limited to the NT- group, both parameters were positively associated with systolic BP.

Discussion: Our results demonstrate for the first time the existence in men of a close association between urinary hyaluronidase activity and vasopressinergic system and suggest that NT+ subjects have a reduced ability to respond to water loading possibly contributing to the blood volume expansion involved in early-stage hypertension. Considering these data, AVP could play a central role in BP regulation by affecting water metabolism through both hyaluronidase activity and AQP2 channel expression.

References

Grassi D, Marraudino M, Garcia-Segura L, Panzica G . The hypothalamic paraventricular nucleus as a central hub for the estrogenic modulation of neuroendocrine function and behavior. Front Neuroendocrinol. 2022; 65:100974. DOI: 10.1016/j.yfrne.2021.100974. View

Cowley Jr A, Monos E, GUYTON A . Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res. 1974; 34(4):505-14. DOI: 10.1161/01.res.34.4.505. View

Rugheimer L, Olerud J, Johnsson C, Takahashi T, Shimizu K, Hansell P . Hyaluronan synthases and hyaluronidases in the kidney during changes in hydration status. Matrix Biol. 2009; 28(7):390-5. DOI: 10.1016/j.matbio.2009.07.002. View

Sladek C, Blair M, Mangiapane M . Evidence against a pressor role for vasopressin in spontaneous hypertension. Hypertension. 1987; 9(4):332-8. DOI: 10.1161/01.hyp.9.4.332. View

Padfield P, Brown J, Lever A, Morton J, Robertson J . Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion. N Engl J Med. 1981; 304(18):1067-70. DOI: 10.1056/NEJM198104303041803. View

Bankir L, Bichet D, Bouby N . Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?. Am J Physiol Renal Physiol. 2010; 299(5):F917-28. DOI: 10.1152/ajprenal.00413.2010. View

Ivanova L, Babina A, Baturina G, Katkova L . Effect of vasopressin on the expression of genes for key enzymes of hyaluronan turnover in Wistar Albino Glaxo and Brattleboro rat kidneys. Exp Physiol. 2013; 98(11):1608-19. DOI: 10.1113/expphysiol.2013.073163. View

Botzki A, Rigden D, Braun S, Nukui M, Salmen S, Hoechstetter J . L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J Biol Chem. 2004; 279(44):45990-7. DOI: 10.1074/jbc.M406146200. View

Fallacara A, Baldini E, Manfredini S, Vertuani S . Hyaluronic Acid in the Third Millennium. Polymers (Basel). 2019; 10(7). PMC: 6403654. DOI: 10.3390/polym10070701. View

10.

Comper W, Laurent T . Physiological function of connective tissue polysaccharides. Physiol Rev. 1978; 58(1):255-315. DOI: 10.1152/physrev.1978.58.1.255. View

11.

Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A . Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med. 2014; 52(10):1447-56. DOI: 10.1515/cclm-2014-0379. View

12.

Verzicco I, Tedeschi S, Graiani G, Bongrani A, Carnevali M, Dancelli S . Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats. Front Cardiovasc Med. 2022; 9:897244. PMC: 9198251. DOI: 10.3389/fcvm.2022.897244. View

13.

Warren A, Grossmann M, Christ-Crain M, Russell N . Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management. Endocr Rev. 2023; 44(5):819-861. PMC: 10502587. DOI: 10.1210/endrev/bnad010. View

14.

Kawano Y, Matsuoka H, Nishikimi T, Takishita S, Omae T . The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens. 1997; 10(11):1240-4. DOI: 10.1016/s0895-7061(97)00269-0. View

15.

Kobayashi T, Chanmee T, Itano N . Hyaluronan: Metabolism and Function. Biomolecules. 2020; 10(11). PMC: 7695009. DOI: 10.3390/biom10111525. View

16.

Goransson V, Johnsson C, Nylander O, Hansell P . Renomedullary and intestinal hyaluronan content during body water excess: a study in rats and gerbils. J Physiol. 2002; 542(Pt 1):315-22. PMC: 2290385. DOI: 10.1113/jphysiol.2001.014894. View

17.

Rugheimer L, Johnsson C, Maric C, Hansell P . Hormonal regulation of renomedullary hyaluronan. Acta Physiol (Oxf). 2007; 193(2):191-8. DOI: 10.1111/j.1748-1716.2007.01795.x. View

18.

Jin X, Kim W, Kim M, Jung W, Kang H, Hong E . Oestrogen inhibits salt-dependent hypertension by suppressing GABAergic excitation in magnocellular AVP neurons. Cardiovasc Res. 2020; 117(10):2263-2274. PMC: 10616626. DOI: 10.1093/cvr/cvaa271. View

19.

Velasquez M, Skelton M, Cowley Jr A . Water loading and restriction in essential hypertension. Hypertension. 1987; 9(4):407-14. DOI: 10.1161/01.hyp.9.4.407. View

20.

Jordan J, Shannon J, BLACK B, Ali Y, Farley M, Costa F . The pressor response to water drinking in humans : a sympathetic reflex?. Circulation. 2000; 101(5):504-9. DOI: 10.1161/01.cir.101.5.504. View